This week our CEO, Katherine Taylor is heading stateside to speak to scientists and clinicians at a conference on ovarian cancer.
"I’m off to Pittsburgh to the American Association for Cancer Research conference on ovarian cancer. It’s an exciting prospect: a conference for scientists and clinicians that specialise in ovarian cancer. That’s a rare occurrence. I’m looking forward to hearing about the latest research and catching up with some friends old and and new in this specialised, important field.
I’ve been fortunate to be invited to speak as one of a small handful of charity representatives. Our role at the conference is to explain how our organisations help promote ovarian cancer research. Ovarian Cancer Action and our colleagues internationally make a significant contribution to progress in ovarian cancer. Thanks to the support you give our organisations, not only is our investment into research greater, the profile of the disease is also increased. Thank you for all that you do increase investment and understanding.
Ovarian Cancer Action is a enthusiastic advocate for international research collaboration. Every four years we curate our ‘HHMT’ symposium on ovarian cancer – a four day meeting of the great and the good in ovarian cancer research from across the world. The meeting is a forging ground for new ideas, collaborations and a roadmap for research priorities. It’s our way of accelerating change and we’re already planning the 2019 meeting. Watch this space."